Screener
Summit Therapeutics SMMT Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $20.04M.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
FAQ
- What is Summit Therapeutics's total debt?
- Summit Therapeutics (SMMT) reported total debt of $20.04M in Q1 2026.
- How has Summit Therapeutics's total debt changed year-over-year?
- Summit Therapeutics's total debt increased by 210.7% year-over-year, from $6.45M to $20.04M.
- What is the long-term trend for Summit Therapeutics's total debt?
- Over 5 years (2020 to 2025), Summit Therapeutics's total debt has grown at a 114.0% compound annual growth rate (CAGR), from $465K to $20.89M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Summit Therapeutics's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude